Your session is about to expire
← Back to Search
Argos Biometer for Cataract
N/A
Recruiting
Led By H J Shammas, MD
Research Sponsored by Shammas Eye Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months postoperative
Awards & highlights
Summary
This study is a prospective, multi-site, multi-surgeon, observational study of refractive accuracy with the Argos using BTAL after successful cataract surgery. Subjects will be assessed pre-operatively, operatively and at 5-8 weeks postoperatively. Clinical evaluations will include measurement of visual acuity, manifest refraction, and preoperative biometry.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months postoperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months postoperative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
The Mean Predictive Errors in the short eyes and in the long eyes
Trial Design
1Treatment groups
Experimental Treatment
Group I: Argos BiometerExperimental Treatment1 Intervention
Preoperative biometry with the Argos device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Argos
2021
N/A
~290
Find a Location
Who is running the clinical trial?
Shammas Eye Medical CenterLead Sponsor
SengiIndustry Sponsor
24 Previous Clinical Trials
1,256 Total Patients Enrolled
13 Trials studying Cataract
564 Patients Enrolled for Cataract
H J Shammas, MDPrincipal InvestigatorShammes Eye Medical Center
Share this study with friends
Copy Link
Messenger